correction: a randomized controlled trial investigating the effects of pcso-524®, a patented oil...

1
CORRECTION Open Access Correction: A randomized controlled trial investigating the effects of PCSO-524®, a patented oil extract of the New Zealand Green Lipped Mussel ( Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 614 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: study protocol ACTRN12610000978066 James D Kean 1 , David Camfield 1 , Jerome Sarris 1,2 , Marni Kras 1 , Richard Silberstein 1 , Andrew Scholey 1 and Con Stough 1* The authors have identified an error in this published article [1]. On page 4, under Treatmentsthe milligrams listed have been calculated incorrectly. The sentence: The Lyprinol capsules contain 18% EPA (46.8 mg) and 14% DHA (36.4 mg) per capsule.Should read: The Lyprinol capsules contain approximately 14% EPA (7.3 mg) and 11% DHA (5.5 mg) per capsule.We apologize for this error. Author details 1 Centre for Human Psychopharmacology, Swinburne University of Technology, PO Box 218 Hawthorn, Melbourne, Victoria 3122, Australia. 2 Department of Psychiatry, University of Melbourne, Melbourne, Australia. Received: 7 August 2013 Accepted: 7 August 2013 Published: 8 August 2013 References 1. Kean JD, Camfield D, Sarris J, Kras M, Silberstein R, Scholey A, Stough C: A randomized controlled trial investigating the effects of PCSO-524(R), a patented oil extract of the New Zealand green lipped mussel (perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6--14 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: study protocol ACTRN1261000097806. Nutr J 2013, 12:100. Jul 16. doi:10.1186/1475-2891-12-113 Cite this article as: Kean et al.: Correction: A randomized controlled trial investigating the effects of PCSO-524®, a patented oil extract of the New Zealand Green Lipped Mussel ( Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 614 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: study protocol ACTRN12610000978066. Nutrition Journal 2013 12:113. Submit your next manuscript to BioMed Central and take full advantage of: Convenient online submission Thorough peer review No space constraints or color figure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit * Correspondence: [email protected] 1 Centre for Human Psychopharmacology, Swinburne University of Technology, PO Box 218 Hawthorn, Melbourne, Victoria 3122, Australia © 2013 Kean et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Kean et al. Nutrition Journal 2013, 12:113 http://www.nutritionj.com/content/12/1/113

Upload: con

Post on 23-Dec-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

CORRECTION Open Access

Correction: A randomized controlled trialinvestigating the effects of PCSO-524®, a patentedoil extract of the New Zealand Green Lipped Mussel(Perna canaliculus), on the behaviour, mood,cognition and neurophysiology of children andadolescents (aged 6–14 years) experiencing clinicaland sub-clinical levels of hyperactivity andinattention: study protocol ACTRN12610000978066James D Kean1, David Camfield1, Jerome Sarris1,2, Marni Kras1, Richard Silberstein1, Andrew Scholey1 and Con Stough1*

The authors have identified an error in this publishedarticle [1].On page 4, under “Treatments” the milligrams listed

have been calculated incorrectly. The sentence:“The Lyprinol capsules contain 18% EPA (46.8 mg)

and 14% DHA (36.4 mg) per capsule.”Should read:“The Lyprinol capsules contain approximately 14%

EPA (7.3 mg) and 11% DHA (5.5 mg) per capsule.”We apologize for this error.

Author details1Centre for Human Psychopharmacology, Swinburne University ofTechnology, PO Box 218 Hawthorn, Melbourne, Victoria 3122, Australia.2Department of Psychiatry, University of Melbourne, Melbourne, Australia.

Received: 7 August 2013 Accepted: 7 August 2013Published: 8 August 2013

References1. Kean JD, Camfield D, Sarris J, Kras M, Silberstein R, Scholey A, Stough C: A

randomized controlled trial investigating the effects of PCSO-524(R), apatented oil extract of the New Zealand green lipped mussel (pernacanaliculus), on the behaviour, mood, cognition and neurophysiology ofchildren and adolescents (aged 6--14 years) experiencing clinical andsub-clinical levels of hyperactivity and inattention: study protocolACTRN1261000097806. Nutr J 2013, 12:100. Jul 16.

doi:10.1186/1475-2891-12-113Cite this article as: Kean et al.: Correction: A randomized controlled trialinvestigating the effects of PCSO-524®, a patented oil extract of the NewZealand Green Lipped Mussel (Perna canaliculus), on the behaviour, mood,cognition and neurophysiology of children and adolescents (aged 6–14 years)experiencing clinical and sub-clinical levels of hyperactivity and inattention:study protocol ACTRN12610000978066. Nutrition Journal 2013 12:113.

Submit your next manuscript to BioMed Centraland take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submit

* Correspondence: [email protected] for Human Psychopharmacology, Swinburne University ofTechnology, PO Box 218 Hawthorn, Melbourne, Victoria 3122, Australia

© 2013 Kean et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the CreativeCommons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, andreproduction in any medium, provided the original work is properly cited.

Kean et al. Nutrition Journal 2013, 12:113http://www.nutritionj.com/content/12/1/113